Considering RKIP is usually downregulated in most cancers, therapeutic strategies involving restoration or mimicking RKIP function holds significant promise due to its tumor-suppressive roles in metastasis, immune modulation, and apoptosis. The gene discussed is PEBP1; the disease is cancer.